Drug-Eluting Stents Could Experience Blockage From New Safety Data
This article was originally published in The Gray Sheet
Executive Summary
Public questions concerning the safety of the Taxus andCypher drug-eluting stents increased measurably last week amid results reported at a major cardiology conference and a disclosure by Boston Scientific that Taxus is associated with an increased risk of blood clots